Gilead Sciences Inc. (GILD)

Gilead Sciences Inc. (GILD $117.86)
- $117.86 P/E (TTM): 24.32X Cap: $143B
- View GILD Profile
- View Questions on GILD

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Amgen Inc. (AMGN $282.73)
- $282.73 P/E (TTM): 22.87X Cap: $152.21B
- View AMGN Profile
- View Questions on AMGN
Gilead Sciences Inc. (GILD $117.86)
- $117.86 P/E (TTM): 24.32X Cap: $143B
- View GILD Profile
- View Questions on GILD
AbbVie Inc. (ABBV $220.22)
- $220.22 P/E (TTM): 89.92X Cap: $373.87B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $132.65)
- $132.65 P/E (TTM): 16.56X Cap: $225.14B
- View ABT Profile
- View Questions on ABT
The Cigna Group (CI $305.87)
- $305.87 P/E (TTM): 16.59X Cap: $80.72B
- View CI Profile
- View Questions on CI
Johnson & Johnson (JNJ $178.50)
- $178.50 P/E (TTM): 18.93X Cap: $429.88B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $94.25)
- $94.25 P/E (TTM): 26.06X Cap: $120.89B
- View MDT Profile
- View Questions on MDT
Savaria Corporation (SIS $20.68)
- $20.68 P/E (TTM): 26.62X Cap: $1.47B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: I am mostly content with my health care stocks with the exception of MDT. It has been essentially flat since about 2016 except for the dividend. It did peak around 2022 but has fallen down to previous levels.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.

Read Answer Asked by Tulio on August 21, 2025

Gilead Sciences Inc. (GILD $117.86)
- $117.86 P/E (TTM): 24.32X Cap: $143B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $455.85)
- $455.85 P/E (TTM): 65.12X Cap: $161.30B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $220.22)
- $220.22 P/E (TTM): 89.92X Cap: $373.87B
- View ABBV Profile
- View Questions on ABBV
Johnson & Johnson (JNJ $178.50)
- $178.50 P/E (TTM): 18.93X Cap: $429.88B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $756.28)
- $756.28 P/E (TTM): 61.07X Cap: $715.78B
- View LLY Profile
- View Questions on LLY
Medtronic plc. (MDT $94.25)
- $94.25 P/E (TTM): 26.06X Cap: $120.89B
- View MDT Profile
- View Questions on MDT
Stryker Corporation (SYK $388.79)
- $388.79 P/E (TTM): 52.02X Cap: $146.41B
- View SYK Profile
- View Questions on SYK
Thermo Fisher Scientific Inc (TMO $491.41)
- $491.41 P/E (TTM): 27.9X Cap: $185.56B
- View TMO Profile
- View Questions on TMO
Health Care Select Sector SPDR (XLV $139.72)
- $139.72 P/E (TTM): 23.54X Cap: $34.77B
- View XLV Profile
- View Questions on XLV
iShares U.S. Medical Devices ETF (IHI $61.78)
- $61.78 P/E (TTM): 28.37X Cap: $4.29B
- View IHI Profile
- View Questions on IHI
Sabra Health Care REIT Inc. (SBRA $19.13)
- $19.13 P/E (TTM): 31.8X Cap: $4.56B
- View SBRA Profile
- View Questions on SBRA
Healthcare Realty Trust Incorporated (HR $18.31)
- $18.31 Cap: $6.35B
- View HR Profile
- View Questions on HR
iShares U.S. Pharmaceuticals ETF (IHE $71.74)
- $71.74 P/E (TTM): 19.44X Cap: $581M
- View IHE Profile
- View Questions on IHE
Catalyst Pharmaceuticals Inc. (CPRX $20.25)
- $20.25 P/E (TTM): 12.12X Cap: $2.47B
- View CPRX Profile
- View Questions on CPRX

Q: There was an article in the Globe and Mail today by David Rosenberg about the aging population and he suggested health care related investments such as health care REITS, pharma, devices, and services. What do you think of this idea and can you give me a few recommendations in canada and the US for each of the 4 categories (health reits, pharma, devices, sefrvices)? A mix of ETFS and individual stocks would be great.

Read Answer Asked by Carla on July 08, 2025

Gilead Sciences Inc. (GILD $117.86)
- $117.86 P/E (TTM): 24.32X Cap: $143B
- View GILD Profile
- View Questions on GILD
Intuitive Surgical Inc. (ISRG $455.85)
- $455.85 P/E (TTM): 65.12X Cap: $161.30B
- View ISRG Profile
- View Questions on ISRG
AbbVie Inc. (ABBV $220.22)
- $220.22 P/E (TTM): 89.92X Cap: $373.87B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $756.28)
- $756.28 P/E (TTM): 61.07X Cap: $715.78B
- View LLY Profile
- View Questions on LLY
Stryker Corporation (SYK $388.79)
- $388.79 P/E (TTM): 52.02X Cap: $146.41B
- View SYK Profile
- View Questions on SYK
Harvest Healthcare Leaders Income ETF (HHL $7.32)
- $7.32 P/E (TTM): 72.11X Cap: $1.40B
- View HHL Profile
- View Questions on HHL
Catalyst Pharmaceuticals Inc. (CPRX $20.25)
- $20.25 P/E (TTM): 12.12X Cap: $2.47B
- View CPRX Profile
- View Questions on CPRX

Q: Seems the whole Healthcare sector stocks are depressed right now. Aside from ISRG (owned) which five are the most compelling to own and at what entry price are they wotth it? Canadian would be best, or ADRs. But I'll take US or world suggestions also.
Thank you!

Read Answer Asked by Roger on June 27, 2025